Wu said that according to PR Newswire, the US biopharmaceutical company Hoth Therapeutics, Inc. announced that the company's board of directors approved the purchase of up to $1 million in Bitcoin. Hoth CEO Robb Knie said: "We believe that Bitcoin will become a strong fiscal reserve asset. Bitcoin's anti-inflation properties may make it a reliable asset with value storage functions."